Injections may help alleviate low moods while promoting a sense of well-being
When discontinuing tirzepatide, clinicians should recognize that effects may persist for 2 to 3 weeks after the last dose due to residual drug levels
GLP-1 drugs were originally developed decades ago as diabetes treatments that alter the hormonal makeup of the brain and gut reducing hunger and slowing digestion
For the general population without these risk factors, the theoretical concern remains speculative
For the majority of people, I recommend once weekly for 4 weeks
During treatment, the one-year incidence of events was 1.3% for acute coronary syndromes, 13.2% for coronary artery disease, 7.3% for heart failure, 1.9% for stroke, and 0.06% for all-cause mortality